Drugs targeting the glucagon-like peptide 1 receptor (GLP-1R) offer several positive effects for individuals with type 2 ...

France’s medicines agency has referred multiple cases to prosecutors and has filed 20 reports against illicit sites through its cybercrime platform, Pharos.

GLP-1 is a natural human hormone that regulates blood glucose levels. Scientists have now created long-lasting GLP-1 drugs ...

GLP‑1–pathway agonists such as semaglutide and newer multi‑agonists have transformed care for obesity and diabetes, yet ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that two abstracts highlighting data on DA-1726, a novel, dual ...

For years, MASH was where drug development dreams went to die.  | After Rezdiffra’s approval and Wegovy’s label expansion, ...

As GLP-1 weight-loss drugs like Ozempic reshape how consumers eat, food and beverage manufacturers are racing to develop ...

GLP-1–pathway agonists such as semaglutide and newer multi-agonists have transformed care for obesity and diabetes, yet developers still wrestle with durability, tissue targeting, and signal "bias." ...

Discover how FTIR spectroscopy enhances quality control in GLP-1 weight loss drug production by ensuring molecular ...

Could taking popular GLP-1 weight loss drugs help curb alcohol use? Well, researchers say they already are. Taking semaglutide and liraglutide — a lesser-known active ingredient — medications for ...

The global GLP-1 Agonists Market, valued at US$53.74 billion in 2024, stood at US$64.42 billion in 2025 and is projected to advance at ...